The superiority of high‐power short‐duration radiofrequency catheter ablation strategy for atrial fibrillation treatment: A systematic review and meta‐analysis study. Issue 4 (2nd July 2021)
- Record Type:
- Journal Article
- Title:
- The superiority of high‐power short‐duration radiofrequency catheter ablation strategy for atrial fibrillation treatment: A systematic review and meta‐analysis study. Issue 4 (2nd July 2021)
- Main Title:
- The superiority of high‐power short‐duration radiofrequency catheter ablation strategy for atrial fibrillation treatment: A systematic review and meta‐analysis study
- Authors:
- Waranugraha, Yoga
Rizal, Ardian
Firdaus, Achmad J.
Sihotang, Fransiska A.
Akbar, Akita R.
Lestari, Defyna D.
Firdaus, Muhammad
Nurudinulloh, Akhmad I. - Abstract:
- Abstract: Background: Radiofrequency catheter ablation (RFCA) using the high‐power short duration (HPSD) results in better ablation lesion formation in the swine model. This systematic review and meta‐analysis purposed to investigate the safety and efficacy profile between HPSD and low‐power long‐duration (LPLD) ablation strategies to treat atrial fibrillation (AF) patients. Methods: We completed the literature review after identifying the relevant articles comparing HPSD and LPLD ablation methods for AF recorded in ClinicalTrials.com, CENTRAL, PubMed, and ScienceDirect until February 2021. The overall effects were calculated using pooled risk ratio (RR) and mean difference (MD) for categorical and continuous data, respectively. We also estimated the 95% confidence interval (CI). Results: The HPSD strategy took shorter procedure time (MD = −33.75 min; 95% CI = −44.54 to −22.97; P < .01), fluoroscopy time (MD = −5.73 min; 95% CI = −8.77 to −2.70; P < .001), and ablation time (MD = −17.71; 95% CI = −21.02 to −14.41) than LPLD strategy. The HPSD RFCA was correlated with lower risk of esophageal thermal injury (RR = 0.75; 95% CI = 0.59 to 0.94; P = .02). The HPSD method resulted in higher first‐pass pulmonary vein isolation (PVI) (RR = 1.36; 95% CI = 1.13 to 1.64; P < .01), lower PV reconnection (RR = 0.47; 95% CI = 0.34 to 0.64; P < .01), and lower recurrent AF (RR = 0.72; 95% CI = 0.54 to 0.96; P = .02) than LPLD strategy. Conclusion: HPSD RFCA was superior to the conventionalAbstract: Background: Radiofrequency catheter ablation (RFCA) using the high‐power short duration (HPSD) results in better ablation lesion formation in the swine model. This systematic review and meta‐analysis purposed to investigate the safety and efficacy profile between HPSD and low‐power long‐duration (LPLD) ablation strategies to treat atrial fibrillation (AF) patients. Methods: We completed the literature review after identifying the relevant articles comparing HPSD and LPLD ablation methods for AF recorded in ClinicalTrials.com, CENTRAL, PubMed, and ScienceDirect until February 2021. The overall effects were calculated using pooled risk ratio (RR) and mean difference (MD) for categorical and continuous data, respectively. We also estimated the 95% confidence interval (CI). Results: The HPSD strategy took shorter procedure time (MD = −33.75 min; 95% CI = −44.54 to −22.97; P < .01), fluoroscopy time (MD = −5.73 min; 95% CI = −8.77 to −2.70; P < .001), and ablation time (MD = −17.71; 95% CI = −21.02 to −14.41) than LPLD strategy. The HPSD RFCA was correlated with lower risk of esophageal thermal injury (RR = 0.75; 95% CI = 0.59 to 0.94; P = .02). The HPSD method resulted in higher first‐pass pulmonary vein isolation (PVI) (RR = 1.36; 95% CI = 1.13 to 1.64; P < .01), lower PV reconnection (RR = 0.47; 95% CI = 0.34 to 0.64; P < .01), and lower recurrent AF (RR = 0.72; 95% CI = 0.54 to 0.96; P = .02) than LPLD strategy. Conclusion: HPSD RFCA was superior to the conventional LPLD RFCA in terms of safety and efficacy in treating AF patients. Abstract : Radiofrequency catheter ablation (RFCA) using the high‐power short‐duration (HPSD) results in better ablation lesion formation in the swine model. This systematic review and meta‐analysis purposed to investigate the safety and efficacy profile between HPSD and low‐power long‐duration ablation strategies to treat atrial fibrillation (AF) patients. Our systematic review and meta‐analysis study revealed that the HPSD RFCA was a safe, effective, and efficient procedure to treat AF. … (more)
- Is Part Of:
- Journal of arrhythmia. Volume 37:Issue 4(2021)
- Journal:
- Journal of arrhythmia
- Issue:
- Volume 37:Issue 4(2021)
- Issue Display:
- Volume 37, Issue 4 (2021)
- Year:
- 2021
- Volume:
- 37
- Issue:
- 4
- Issue Sort Value:
- 2021-0037-0004-0000
- Page Start:
- 975
- Page End:
- 989
- Publication Date:
- 2021-07-02
- Subjects:
- atrial fibrillation -- catheter ablation -- high‐power short duration -- low‐power long‐duration -- meta‐analysis
Arrhythmia -- Periodicals
Cardiac pacing -- Periodicals
Arrhythmias, Cardiac
Arrhythmia
Cardiac pacing
Periodicals
Electronic journals
Periodicals
616.128 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1883-2148/issues ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/joa3.12590 ↗
- Languages:
- English
- ISSNs:
- 1880-4276
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 18452.xml